DE69725988D1 - Polynukleotid-impfstoff, vorzugsweise zur behandlung der atemkrankheit bei rindern - Google Patents
Polynukleotid-impfstoff, vorzugsweise zur behandlung der atemkrankheit bei rindernInfo
- Publication number
- DE69725988D1 DE69725988D1 DE69725988T DE69725988T DE69725988D1 DE 69725988 D1 DE69725988 D1 DE 69725988D1 DE 69725988 T DE69725988 T DE 69725988T DE 69725988 T DE69725988 T DE 69725988T DE 69725988 D1 DE69725988 D1 DE 69725988D1
- Authority
- DE
- Germany
- Prior art keywords
- cattle
- preferred
- respiratory disease
- treat respiratory
- polynucleotide vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/813—Viral vaccine for bovine species, e.g. cattle
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9609403 | 1996-07-19 | ||
FR9609403A FR2751229B1 (fr) | 1996-07-19 | 1996-07-19 | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
PCT/FR1997/001325 WO1998003200A2 (fr) | 1996-07-19 | 1997-07-16 | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69725988D1 true DE69725988D1 (de) | 2003-12-11 |
DE69725988T2 DE69725988T2 (de) | 2004-11-11 |
Family
ID=9494497
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69734483T Expired - Lifetime DE69734483T2 (de) | 1996-07-19 | 1997-07-16 | Polynukleotid-Impfstoff, vorzugsweise zur Behandlung der Atemkrankheit bei Rindern |
DE69725988T Expired - Lifetime DE69725988T2 (de) | 1996-07-19 | 1997-07-16 | Polynukleotid-impfstoff, vorzugsweise zur behandlung der atemkrankheit bei rindern |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69734483T Expired - Lifetime DE69734483T2 (de) | 1996-07-19 | 1997-07-16 | Polynukleotid-Impfstoff, vorzugsweise zur Behandlung der Atemkrankheit bei Rindern |
Country Status (28)
Country | Link |
---|---|
US (2) | US6376473B1 (de) |
EP (2) | EP1382348B1 (de) |
JP (1) | JP2000516200A (de) |
AP (1) | AP9701044A0 (de) |
AR (1) | AR007862A1 (de) |
AT (2) | ATE253376T1 (de) |
AU (1) | AU734442B2 (de) |
BR (1) | BR9710506A (de) |
CA (1) | CA2260855C (de) |
CO (1) | CO4700306A1 (de) |
CZ (2) | CZ298915B6 (de) |
DE (2) | DE69734483T2 (de) |
DK (2) | DK0912194T3 (de) |
ES (2) | ES2254833T3 (de) |
FR (1) | FR2751229B1 (de) |
HR (1) | HRP970383A2 (de) |
HU (2) | HU228353B1 (de) |
ID (1) | ID19513A (de) |
IL (2) | IL127703A0 (de) |
MA (1) | MA24269A1 (de) |
NZ (4) | NZ508939A (de) |
PE (1) | PE84699A1 (de) |
PL (1) | PL190122B1 (de) |
PT (1) | PT912194E (de) |
RU (1) | RU2305560C2 (de) |
UA (1) | UA70914C2 (de) |
WO (1) | WO1998003200A2 (de) |
ZA (1) | ZA976283B (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2751229B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
US7078388B2 (en) | 2000-01-21 | 2006-07-18 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
FR2804028B1 (fr) * | 2000-01-21 | 2004-06-04 | Merial Sas | Vaccins adn ameliores pour animaux de rente |
US20040002472A1 (en) * | 2000-01-21 | 2004-01-01 | Audonnet Jean-Christophe Francis | Vaccination or immunization using a prime-boost regimen |
US6852705B2 (en) * | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
EP2390352A1 (de) | 2003-03-18 | 2011-11-30 | Quantum Genetics Ireland Limited | Systeme und Methoden zur Erhöhung der Milchproduktion bei Tieren |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
EP1689858B1 (de) | 2003-11-13 | 2013-05-15 | University Of Georgia Research Foundation, Inc. | Verfahren zur charakterisierung des ibd (infectious bursal disease)-virus |
NZ549384A (en) | 2004-02-19 | 2008-08-29 | Univ Alberta | Leptin promoter polymorphisms and uses thereof |
RS51324B (sr) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
JP2009515529A (ja) | 2005-11-14 | 2009-04-16 | メリアル リミテッド | 腎不全のための遺伝子療法 |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
WO2008136790A1 (en) | 2007-05-02 | 2008-11-13 | Merial Limited | Dna plasmids having improved expression and stability |
US20080274137A1 (en) * | 2007-05-02 | 2008-11-06 | Jean Christophe Francis Audonnet | DNA plasmids having improved expression and stability |
MX2011005604A (es) | 2008-11-28 | 2011-09-01 | Merial Ltd | Vacuna recombinante para influenza aviar y sus usos. |
KR101715418B1 (ko) | 2009-04-03 | 2017-03-10 | 메리얼 인코포레이티드 | 뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신 |
WO2011090708A2 (en) | 2009-12-28 | 2011-07-28 | Merial Limited | Recombinant ndv antigen and uses thereof |
AU2011207626B2 (en) | 2010-01-19 | 2015-06-18 | President And Fellows Of Harvard College | Engineered opsonin for pathogen detection and treatment |
US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
AU2011224188B2 (en) | 2010-03-12 | 2015-01-22 | Boehringer Ingelheim Animal Health USA Inc. | Bluetongue virus recombinant vaccines and uses thereof |
US8986706B2 (en) | 2010-08-31 | 2015-03-24 | Merial, Inc. | Newcastle disease virus vectored herpesvirus vaccines |
AR084358A1 (es) * | 2010-12-27 | 2013-05-08 | Lilly Co Eli | Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc)) |
WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
WO2012138783A2 (en) | 2011-04-04 | 2012-10-11 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment |
EP2694678A2 (de) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Verfahren und zusammensetzungen zur vorhersage der resistenz gegenüber einer antikrebsbehandlung |
WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
AP2013007180A0 (en) | 2011-04-25 | 2013-10-31 | Advanced Bioscience Lab Inc | Truncated HIV envelope proteins (ENV), methods andcompositions related thereto |
AU2012262740B2 (en) | 2011-05-27 | 2017-06-01 | Boehringer Ingelheim Animal Health USA Inc. | Genetic vaccines against Hendra virus and Nipah virus |
EP2714077B1 (de) | 2011-06-01 | 2018-02-28 | Merial, Inc. | Nadellose verabreichung von prrsv-impfstoffen |
SG10201608671SA (en) | 2011-07-18 | 2016-12-29 | Harvard College | Engineered Microbe-Targeting Molecules and Uses Thereof |
EA031229B1 (ru) | 2011-08-12 | 2018-12-28 | Мериал, Инк. | Способ витрификации биологического материала |
WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
US20130177591A1 (en) | 2012-01-10 | 2013-07-11 | Merial Limited | Lipid Based Adjuvants for DNA Plasmids |
ES2866108T3 (es) | 2012-02-14 | 2021-10-19 | Boehringer Ingelheim Animal Health Usa Inc | Vectores poxvirales recombinantes que expresan proteínas de la rabia y OX40 y vacunas fabricadas a partir de los mismos |
ES2632429T3 (es) | 2012-02-14 | 2017-09-13 | Merial, Inc. | Vacunas subunitarias de rotavirus y procedimientos para la fabricación y utilización de las mismas |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
MA37749B1 (fr) | 2012-06-13 | 2017-05-31 | Merial Ltd | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine |
SG11201500696VA (en) | 2012-08-01 | 2015-02-27 | Bavarian Nordic As | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
EP2968514A1 (de) | 2013-03-12 | 2016-01-20 | Merial, Inc. | Mittels reverser genetik hergestellte impfstoffzusammensetzungen gegen schmallenberg-virus und verfahren zur verwendung davon |
EP2976642A4 (de) | 2013-03-15 | 2016-09-21 | Harvard College | Verfahren und zusammensetzungen zur verbesserung der erkennung und/oder aufnahme einer zieleinheit |
CA2913155A1 (en) | 2013-05-21 | 2014-11-27 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof |
US10513546B2 (en) | 2013-12-18 | 2019-12-24 | President And Fellows Of Harvard College | CRP capture/detection of gram positive bacteria |
WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
BR112017027895A2 (pt) | 2015-06-23 | 2018-11-06 | Merial Inc | vetores virais recombinantes contendo proteínas menores de prrsv e métodos de fabricação e utilização destes |
EP3331549B1 (de) | 2015-08-06 | 2020-12-23 | President and Fellows of Harvard College | Verbesserte mikrobenbindende moleküle und verwendungen davon |
WO2017031120A1 (en) | 2015-08-20 | 2017-02-23 | Merial, Inc. | Fcv recombinant vaccines and uses thereof |
MA43016A (fr) | 2015-09-29 | 2018-08-08 | Merial Inc | Vaccins à particules pseudo-virales (vlp) de parvovirus canin (cpv) et utilisations associées |
CA3006078A1 (en) | 2015-11-23 | 2017-06-01 | Merial, Inc. | Fmdv and e2 fusion proteins and uses thereof |
TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
CN109021081B (zh) * | 2018-08-10 | 2019-06-04 | 山东大学 | 一种牛病毒性腹泻病毒样颗粒及其构建方法与应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE105334T1 (de) * | 1988-04-22 | 1994-05-15 | Upjohn Co | Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3. |
WO1992001471A1 (en) * | 1990-07-24 | 1992-02-06 | The Uab Research Foundation | Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
CA2136677A1 (en) * | 1993-12-29 | 1995-06-30 | Intervet, Inc. | Method of intranasally administering to bovines a trivalent vaccine containing modified live ibrv, pl3v and brsv |
ATE475668T1 (de) * | 1994-01-27 | 2010-08-15 | Univ Massachusetts Medical | Immunisierung durch impfung von dns transkriptionseinheit |
US5541102A (en) * | 1994-09-02 | 1996-07-30 | Board Of Regents, University Of Nebraska-Lincoln | Bovine cell line resistant to in vitro infection by bovine viral diarrhea virus and all other known pestiviruses |
US6019980A (en) | 1995-06-07 | 2000-02-01 | Connaught Laboratories Limited | Nucleic acid respiratory syncytial virus vaccines |
US6060457A (en) | 1996-06-20 | 2000-05-09 | Universite De Montreal | DNA plasmid vaccine for immunization of animals against BVDV |
FR2751229B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
JP5566663B2 (ja) * | 2009-11-09 | 2014-08-06 | 三菱重工業株式会社 | 多翼遠心ファンおよびそれを用いた空気調和機 |
-
1996
- 1996-07-19 FR FR9609403A patent/FR2751229B1/fr not_active Expired - Lifetime
-
1997
- 1997-07-06 NZ NZ508939A patent/NZ508939A/en not_active IP Right Cessation
- 1997-07-06 NZ NZ508940A patent/NZ508940A/xx not_active IP Right Cessation
- 1997-07-06 NZ NZ517686A patent/NZ517686A/xx not_active IP Right Cessation
- 1997-07-11 AR ARP970103111A patent/AR007862A1/es active IP Right Grant
- 1997-07-15 HR HR9609403A patent/HRP970383A2/hr not_active Application Discontinuation
- 1997-07-16 MA MA24716A patent/MA24269A1/fr unknown
- 1997-07-16 HU HU0500910A patent/HU228353B1/hu unknown
- 1997-07-16 AU AU37735/97A patent/AU734442B2/en not_active Expired
- 1997-07-16 BR BR9710506A patent/BR9710506A/pt not_active Application Discontinuation
- 1997-07-16 CZ CZ20070776A patent/CZ298915B6/cs not_active IP Right Cessation
- 1997-07-16 ZA ZA976283A patent/ZA976283B/xx unknown
- 1997-07-16 DE DE69734483T patent/DE69734483T2/de not_active Expired - Lifetime
- 1997-07-16 JP JP09535655A patent/JP2000516200A/ja active Pending
- 1997-07-16 CZ CZ0017599A patent/CZ298898B6/cs not_active IP Right Cessation
- 1997-07-16 HU HU9902791A patent/HU225169B1/hu unknown
- 1997-07-16 UA UA99020960A patent/UA70914C2/uk unknown
- 1997-07-16 WO PCT/FR1997/001325 patent/WO1998003200A2/fr active IP Right Grant
- 1997-07-16 DE DE69725988T patent/DE69725988T2/de not_active Expired - Lifetime
- 1997-07-16 DK DK97934578T patent/DK0912194T3/da active
- 1997-07-16 DK DK03016996T patent/DK1382348T3/da active
- 1997-07-16 CA CA2260855A patent/CA2260855C/en not_active Expired - Lifetime
- 1997-07-16 ID IDP972480A patent/ID19513A/id unknown
- 1997-07-16 PL PL97331236A patent/PL190122B1/pl unknown
- 1997-07-16 AT AT97934578T patent/ATE253376T1/de active
- 1997-07-16 EP EP03016996A patent/EP1382348B1/de not_active Expired - Lifetime
- 1997-07-16 ES ES03016996T patent/ES2254833T3/es not_active Expired - Lifetime
- 1997-07-16 IL IL12770397A patent/IL127703A0/xx active IP Right Grant
- 1997-07-16 AT AT03016996T patent/ATE307607T1/de active
- 1997-07-16 EP EP97934578A patent/EP0912194B1/de not_active Expired - Lifetime
- 1997-07-16 ES ES97934578T patent/ES2210548T3/es not_active Expired - Lifetime
- 1997-07-16 NZ NZ333751A patent/NZ333751A/en not_active IP Right Cessation
- 1997-07-16 PT PT97934578T patent/PT912194E/pt unknown
- 1997-07-17 AP APAP/P/1997/001044A patent/AP9701044A0/en unknown
- 1997-07-18 CO CO97040983A patent/CO4700306A1/es unknown
-
1998
- 1998-01-16 PE PE1998000035A patent/PE84699A1/es not_active Application Discontinuation
- 1998-12-23 IL IL127703A patent/IL127703A/en not_active IP Right Cessation
-
1999
- 1999-01-15 US US09/232,279 patent/US6376473B1/en not_active Expired - Lifetime
-
2002
- 2002-02-28 US US10/085,519 patent/US6818628B2/en not_active Expired - Lifetime
- 2002-12-05 RU RU2002132831/13A patent/RU2305560C2/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69725988D1 (de) | Polynukleotid-impfstoff, vorzugsweise zur behandlung der atemkrankheit bei rindern | |
DE69734778D1 (de) | Polynukleotid-impfstoffformulierung gegen pferdekrankheiten | |
DE59712045D1 (de) | Vorrichtung zur behandlung des herzens | |
ATE247987T1 (de) | Behandlung zur beseitigung von gerüchen | |
ATE224732T1 (de) | Intradermaler polynukleotid-impfstoff aus rind | |
DE69528303D1 (de) | Vorrichtung zur thermischen Behandlung | |
DE69727878D1 (de) | Eine Vorrichtung zur Behandlung von Tachykardie durch Stimulation des Atmungssystems | |
ATE306481T1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE69734284D1 (de) | Zusammensetzung eines polynukleotidvakzins zur behandlung von atemwegs- und fortpflanzungsbezogenen erkrankungen des schweins | |
DE69939058D1 (de) | Vorrichtung zur behandlung von peripheren gefässerkrankungen | |
DE59500555D1 (de) | Mittel zur Wasserbehandlung | |
GB2319725B (en) | Extracting particles produced by the treating of human or animal nails | |
DE29602789U1 (de) | Liege, Decke o.dgl. zur therapeutischen Behandlung von Lebewesen | |
DE69506019T2 (de) | Vorrichtung zur Behandlung von Schmerz | |
DE69701250D1 (de) | Tierbehandlungsvorrichtung | |
DE69737067D1 (de) | Vakzine zur behandlung von mycosen | |
DE69533245D1 (de) | Vorrichtung zur elektrolytischen Behandlung | |
DE69709579D1 (de) | System zur Überwachung von Biozidbehandlungen | |
DE29818305U1 (de) | Einrichtung zur Behandlung von Tieren, insbesondere Pferden | |
KR970027134U (ko) | 건강증진용 찜질 매트 | |
DE29708309U1 (de) | Vorrichtung zur physiotherapeutischen Behandlung | |
DE59004144D1 (de) | Mittel zur Entwöhnung des Tabakgenusses. | |
DE29614112U1 (de) | Auswechselbare Laufflächen, Hufbeschlagssystem zur Vermeidung von Prellungen | |
DE29612101U1 (de) | Behandlungsliege | |
DE29707045U1 (de) | Vorrichtung zur Steigerung des menschlichen Wohlbefindens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |